Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States.

Sullivan PW, Ghushchyan V, Ben-Joseph RH.

Obesity (Silver Spring). 2008 Sep;16(9):2155-62. doi: 10.1038/oby.2008.325.

2.

Overweight and obesity: an overview of prevalence, clinical impact, and economic impact.

Friedman N, Fanning EL.

Dis Manag. 2004 Fall;7 Suppl 1:S1-6. Review. No abstract available.

PMID:
15669572
3.

Cost and policy implications from the increasing prevalence of obesity and diabetes mellitus.

Ryan JG.

Gend Med. 2009;6 Suppl 1:86-108. doi: 10.1016/j.genm.2009.01.002. Review.

PMID:
19318221
4.

Current estimates of the economic cost of obesity in the United States.

Wolf AM, Colditz GA.

Obes Res. 1998 Mar;6(2):97-106. Review.

5.

The medical costs attributable to meat consumption.

Barnard ND, Nicholson A, Howard JL.

Prev Med. 1995 Nov;24(6):646-55. Review.

PMID:
8610089
6.

What is the economic case for treating obesity?

Wolf AM.

Obes Res. 1998 Apr;6 Suppl 1:2S-7S. Review.

7.
8.

[Cardiovascular risk factors].

Bruckner II.

Med Interna. 1993;45(1-2):14-23. Review. Romanian. No abstract available.

PMID:
8081687
9.

Hypertension and other cardiovascular risk factors in women.

Wenger NK.

Am J Hypertens. 1995 Dec;8(12 Pt 2):94s-99s. Review.

PMID:
8845099
10.
11.

[An economic review of the management of diabetes mellitus].

Tsujii S.

Nihon Rinsho. 2002 Oct;60 Suppl 10:623-30. Review. Japanese. No abstract available.

PMID:
12430293
12.

How big of a problem is obesity?

Finkelstein EA.

Surg Obes Relat Dis. 2014 Jul-Aug;10(4):569-70. doi: 10.1016/j.soard.2014.02.028. Epub 2014 Mar 1. Review. No abstract available.

PMID:
24958649
13.

[Current trend of hyperlipidemia in Japan--comparison with the trend in United States and Europe].

Arai H.

Nihon Rinsho. 2007 Jul 28;65 Suppl 7:241-7. Review. Japanese. No abstract available.

PMID:
17824042
14.

Recommendation to Reduce Patients' Blood Pressure and Cholesterol Medication Costs.

Fielding JE, Rimer BK, Johnson RL, Orleans CT, Calonge N, Clymer JM, Glanz K, Goetzel RZ, Green LW, Ramirez G, Pronk NP; Community Preventive Services Task Force.

Prev Chronic Dis. 2015 Nov 25;12:E209. doi: 10.5888/pcd12.150253. Review. No abstract available.

Supplemental Content

Support Center